version: English | 中文版
多肽合成
热销产品
目录多肽

P物质及同类物

Peptide Name

CAT#

Peptide Sequence

Antagonist G

1966-2-1

Arg-DTrp-NMe-Phe-DTrp-Leu-Met-NH2

Scyliorhinin I, amide, dogfish

1966-2-2

Ala-Lys-Phe-Asp-Lys-Phe-Tyr-Gly-Leu-Met-NH2

Scyliorhinin II, amide, dogfish

1966-2-3

Ser-Pro-Ser-Asn-Ser-Lys-Cys-Pro-Asp-Gly-Pro-Asp-Cys-Phe-Val-Gly-Leu-Met-NH2

Spantide II

1966-2-4

DLys(Nicotinoyl)-Pro-(3-Pyridyl)Ala-Pro-(3,4-dichloro)DPhe-Asn-DTrp-Phe-DTrp-Leu-Nle-NH2

Substance P

1966-2-5

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2

Substance P (1-4)

1966-2-6

Arg-Pro-Lys-Pro

Substance P (1-7)

1966-2-7

Arg-Pro-Lys-Pro-Gln-Gln-Phe

Substance P (1-9)

1966-2-8

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly

Substance P (2-11)/Deca-Substance P

1966-2-9

Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2

Substance P (3-11)/Nona-Substance P

1966-2-10

Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2

Substance P (4-11)/Octa-Substance P

1966-2-11

Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2

Substance P (5-11)/Hepta-Substance P

1966-2-12

Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2

Substance P (6-11)/Hexa-Substance P

1966-2-13

Gln-Phe-Phe-Gly-Leu-Met-NH2

Substance P (7-11)

1966-2-14

Phe-Phe-Gly-Leu-Met-NH2

Substance P (9-11)

1966-2-15

Gly-Leu-Met-NH2

Substance P Methyl ester

1966-2-16

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-OMe

Substance P reversed sequence

1966-2-17

Met-Leu-Gly-Phe-Phe-Gln-Gln-Pro-Lys-Pro-Arg-NH2

Substance P, Free Acid

1966-2-18

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met

Substance P-Gly-Lys-Arg

1966-2-19

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-Gly-Lys-Arg

[Arg3] Substance P

1966-2-20

Arg-Pro-Arg-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2

[Asp5,6,Me-Phe8] Substance P

1966-2-21

Asp-Asp-Phe-Me-Phe-Gly-Leu-Met-NH2

[DAla4] Substance P (4-11)

1966-2-22

DAla-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2

[DArg1,DPhe5,DTrp7,9,Leu11] Substance P

1966-2-23

DArg-Pro-Lys-Pro-DPhe-Gln-DTrp-Phe-DTrp-Leu-Leu-NH2

[DArg1,DPro2,DPhe7,DHis9] Substance P

1966-2-24

DArg-DPro-Lys-Pro-Gln-Gln-DPhe-Phe-DHis-Leu-Met-NH2

[DArg1,DPro2,DTrp7,9,Leu11] Substance P

1966-2-25

DArg-DPro-Lys-Pro-Gln-Gln-DTrp-Phe-DTrp-Leu-Leu-NH2

[DArg1,DTrp7,9,Leu11] Substance P

1966-2-26

DArg-Pro-Lys-Pro-Gln-Gln-DTrp-Phe-DTrp-Leu-Leu-NH2

[Dehydro-Pro4] Substance P (4-11)

1966-2-27

Dehydro-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2

[DPro2,DPhe7,DTrp9] Substance P

1966-2-28

Arg-DPro-Lys-Pro-Gln-Gln-DPhe-Phe-DTrp-Leu-Met-NH2

[DPro2,DTrp7,9] Substance P

1966-3-1

Arg-DPro-Lys-Pro-Gln-Gln-DTrp-Phe-DTrp-Leu-Met-NH2

[DPro4,DTrp7,9,10] Substance P (4-11)

1966-3-2

DPro-Gln-Gln-DTrp-Phe-DTrp-DTrp-Met-NH2

[DPro4,DTrp7,9,Nle11] Substance P (4-11)

1966-3-3

DPro-Gln-Gln-DTrp-Phe-DTrp-Leu-Nle-NH2

[DPro4,DTrp7,9] Substance P (4-11)

1966-3-4

DPro-Gln-Gln-DTrp-Phe-DTrp-Leu-Met-NH2

[DTrp2,7,9] Substance P

1966-3-5

Arg-DTrp-Lys-Pro-Gln-Gln-DTrp-Phe-DTrp-Leu-Met-NH2

[Glp5,(Me)Phe8,Sar9] Substance P (5-11)

1966-3-6

Glp-Gln-Phe-(NMe)Phe-Sar-Leu-Met-NH2

[Glp5,Sar9] Substance P (5-11)

1966-3-7

Glp-Gln-Phe-Phe-Sar-Leu-Met-NH2

[Glp5] Substance P (5-11)

1966-3-8

Glp-Gln-Phe-Phe-Gly-Leu-Met-NH2

[Glp6,Pro9] Substance P (6-11)/Septide

1966-3-9

Glp-Phe-Phe-Pro-Leu-Met-NH2

[Glp6] Substance P (6-11)

1966-3-10

Glp-Phe-Phe-Gly-Leu-Met-NH2

[Gly11] Substance P

1966-3-11

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Gly-NH2

[His11]Substance P

1966-3-12

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-His-NH2

[MePhe8,Sar9] Substance P

1966-3-13

Arg-Pro-Lys-Pro-Gln-Gln-Phe-(NMe)Phe-Sar-Leu-Met-NH2

[Nle11] Substance P

1966-3-14

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Nle-NH2

[Pro9] Substance P

1966-3-15

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Pro-Leu-Met-NH2

[Sar4] Substance P (4-11)

1966-3-16

Sar-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2

[Sar9, Met(O2)11

1966-3-17

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met[O2]-NH2

[Sar9] Substance P

1966-3-18

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met-NH2

[Succinyl-Asp6,Me-Phe8] Substance P

1966-3-19

Succinyl-Asp-Phe-Me-Phe-Gly-Leu-Met-NH2

[Tyr8,Nle11] Substance P

1966-3-20

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Tyr-Gly-Leu-Nle-NH2

[Tyr8] Substance P

1966-3-21

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Tyr-Gly-Leu-Met-NH2

 

  •  上海强耀生物科技有限公司总经理王锡平一行赴清华大学祝贺李海涛教授在Nature子刊上成功发表文章,并与李教授进行了亲切会谈,李教授获悉强耀能够在短短三年发展到如此规模,他感到非常高兴,他表示非常希望能够在自己的研究中尽量多的使用中国的试剂并将中国的试剂推荐给国外的科研人员使用,支持中国的民族企业做大做强。最后李教授给强耀生物提出了一些非常宝贵的建议和意见,并预祝强耀生物能够发展地更顺利。
    (2011年10月21日)
  •  中国科学院病原微生物与免疫学重点实验室2011年度“强耀优秀论文奖”颁奖典礼在微生物研究所A203会议室顺利举行。上海强耀生物科技有限公司总经理王锡平、销售部经理何伶杰、外贸部经理程维新,病原微生物与免疫学重点实验室副主任张立新研究员、中国科学院微生物研究所科技处杨怀义处长、重点实验室课题组长周旭宇研究员及相关科研人员出席了颁奖典礼。
    (2011年10月20日)
  •  更多新闻...
  • 上海强耀生物科技有限公司
    欢迎您来函来电!
    国内市场部
    电话:021-50795728
    传真:021-50795570
    邮件: inside@chinapeptides.com
    国际市场部
    电话:+86-21-50790349
    传真:+86-21-50795570
    邮件: outside@chinapeptides.com
联系我们    |    人才招聘    |    关于我们    |    公司帐户    |    相关下载
上海强耀生物科技有限公司 版权所有  沪ICP备05035057号